Latest Market Strategy News

PT ANTAM (ASX:ATM) posted a 12% rise in gold production in 2Q26 and advanced key downstream projects including EV battery ecosystem development, while securing multiple ESG awards.

PTR Minerals has unveiled a substantial maiden Mineral Resource Estimate for its Rosewood Titanium Project, highlighting a large, high-grade heavy mineral deposit with strong metallurgical potential and strategic team expansions.

Canadian Phosphate has secured a five-year exploration permit for its Wapiti Phosphate Project and commenced a 3,000m drilling campaign, while progressing the pending acquisition of the Diamond Mountain Project in Utah. A $5.2 million capital raise positions the company to accelerate its North American phosphate ambitions.

RareX Limited and Iluka Resources have progressed to the Request for Proposal stage for the Mrima Hill Niobium and Rare Earths Project in Kenya, backed by a A$1.65 billion Australian Government loan for downstream refining.

Harvest Technology Group has inked a non-binding partnership with Ukrainian Technopark to explore integrating its ultra-low-bandwidth Nodestream platform into unmanned defence systems, focusing on resilient communications under electronic warfare conditions.

WAM Income Maximiser (ASX: WMX) has lifted its fully franked monthly dividends for Q4 2026, pushing the annualised yield to 7.1% including franking credits, supported by a robust 17.8% per annum portfolio return since inception and notably lower volatility than the ASX 300.

Ovanti appoints two early Afterpay executives to its Advisory Board as it prepares to relaunch its BNPL platforms IOUPAY and myIOU, targeting rapid growth in Southeast Asia and beyond.

LTR Pharma has formalised its US commercialisation strategy by signing a definitive agreement with telehealth leader Shed, targeting at least 150,000 ROXUS units in the first year through digital men’s health platforms.

Meteoric Resources has expanded its Ore Reserve at the Caldeira Rare Earth Project in Brazil by 42%, underpinning over 20 years of production and reinforcing its Tier 1 status in the global rare earths market.

Compumedics reported a record $60.3 million in FY26 revenue, driven by an 18% year-on-year increase and a 70% jump in SaaS recurring revenues from Somfit and Nexus 360. The company resolved supply chain disruptions and targets faster EBITDA growth in FY27.

The Calmer Co. has won Coles' approval for its innovative Fiji Kava® FZZR™ product, extending its Australian supermarket reach while gearing up for a broader U.S. retail rollout supported by a key brokerage partnership.

FortifAI Limited (ASX: FTI) has laid out its vision for the burgeoning Agentic AI infrastructure sector, spotlighting its Nol8 AI Data Plane technology designed to tackle critical GPU underutilisation and data delivery bottlenecks. The company projects a $120 billion total addressable market by 2030, driven by explosive growth in AI agent workloads and data movement demands.